![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1567232
¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå : Áúȯ À¯Çüº°, ¼ºñ½º À¯Çüº°, Á¦°ø ¹æ½Äº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography |
¼¼°è ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀº 2024³â 57¾ï 1,000¸¸ ´Þ·¯, 2031³â¿¡´Â 138¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 13.4%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ »ó¼¼³»¿ë | ||
---|---|---|---|
±âÁس⵵ | 2023³â | 2024³â ½ÃÀå ±Ô¸ð | 57¾ï 1,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£(2024-2031³â) CAGR: | 13.40% | 2031³â °¡Ä¡ ¿¹Ãø | 138¾ï ´Þ·¯ |
´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ(CVD), ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä µî ¸¸¼ºÁúȯÀº Áö¼ÓÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇϰí ÀÏ»ó»ýȰÀ» Á¦ÇÑÇÏ´Â Àå±âÀûÀÎ °Ç° »óÅÂÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ´ëºÎºÐ ´ã¹è¸¦ ÇÇÇÏ°í °Ç°ÇÑ Ã¼ÁßÀ» À¯ÁöÇÏ´Â µî »ýȰ½À°üÀ» °³¼±ÇÔÀ¸·Î½á ¿¹¹æÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¹Ù»Û ÀÏÁ¤°ú ½ºÆ®·¹½º°¡ ¸¹Àº »ýȰÀº ÀÌ·¯ÇÑ Áõ»óµéÀ» °ü¸®ÇÏ±â ¾î·Æ°Ô ¸¸µì´Ï´Ù. ÀÌ¿¡ µû¶ó ´õ ³ªÀº ¸¸¼ºÁúȯ °ü¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ´Ù¾çÇÑ ±â¼ú ¹ßÀü°ú ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â °¡±î¿î ½ÃÀÏ ³»¿¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¼¼°è ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â ³ëÀÎ Àα¸ Áõ°¡, ºñ¸¸°ú ½Ä½À°ü º¯È·Î ÀÎÇÑ ´ç´¢º´ ¹× ½ÉÇ÷°ü Áúȯ°ú °°Àº »ýȰ½À°üº´ ¹ßº´·ü Áõ°¡, Áúº´ Á¶±â ¹ß°ß ¹× Áúº´ °ü¸®ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, µðÁöÅÐ °Ç° ¼Ö·ç¼ÇÀÇ ±â¼ú ¹ßÀü, ÀÇ·áºñ Áõ°¡¸¦ ¾ïÁ¦Çϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ ¹× ¹Î°£ ÀÇ·áºñ Áõ°¡¸¦ ¾ïÁ¦Çϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ ¹× ¹Î°£´ÜüÀÇ ³ë·Â µîÀÇ ¿äÀο¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ¿ø°Ý ¸ð´ÏÅ͸µ ±â±â ¹× ¼ºñ½º µµÀÔ ºñ¿ë Áõ°¡, °³¹ßµµ»ó±¹ÀÇ ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ ºÎÁ· µîÀÌ ºü¸¥ È®»ê¿¡ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿©·¯ ÁúȯÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â ÅëÇÕ Ç÷§ÆûÀÇ °³¹ß, AI¿Í ¿þ¾î·¯ºí ±â¼úÀÇ ¿ªÇÒ È®´ë, °³ÀÎ ¸ÂÃãÇü Äɾ ´ëÇÑ °ü½É Áõ°¡´Â ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù.
º» º¸°í¼´Â ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.
¼¼°è ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
Á¶»ç ´ë»ó ÁÖ¿ä ±â¾÷À¸·Î´Â IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum(A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, Healthwise µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°è ¸¸¼º Áúȯ °ü¸® ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¸¸¼ºÁúȯ °ü¸® ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
Global chronic disease management market is estimated to be valued at USD 5.71 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 5.71 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 13.40% | 2031 Value Projection: | US$ 13.80 Bn |
Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.
Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.
This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market
Detailed Segmentation-